Prostaglandins and heart disease

Area of Science:

• Cardiovascular Science
• Pharmacology

Background:

• Prostaglandins (PGs) are synthesized in the heart and coronary vessels.
• PG synthesis is affected by physiological and pathological conditions, including ischemia.

Purpose of the Study:

• To review the role of prostaglandins in cardiac pathophysiology.
• To emphasize clinically applied aspects and therapeutic implications of PGs in heart disease.

Main Methods:

• Literature review focusing on prostaglandin synthesis, function, and clinical applications in cardiology.
• Analysis of the balance between thromboxane A2 (TXA2) and prostacyclin (PGI2) in cardiovascular events.

Main Results:

• PGs like PGI2 may inhibit platelet aggregation and promote vasodilation.
• The balance between TXA2 and PGI2 is implicated in angina and myocardial infarction.
• Non-steroidal anti-inflammatory drugs' effects are debated due to potential inhibition of beneficial PGs.

Conclusions:

• PGs play a complex role in cardiac pathophysiology with potential therapeutic applications.
• Further research is needed for stable PG analogues and specific synthesis inhibitors for cardiac disease management.